- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04033744
Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Eighteen young patients with bilateral impacted mandibular third molars will be selected. All 36 cases of impactions will be selected for a split mouth study and randomly treated by using 2 different therapeutic approaches, thereby yielding 2 different study groups, each of which is composed of 18 cases: in one side the post-extraction socket is left healing spontaneously, on the other side the socket is filled with PRF.
CAL at the distal surface of the lower second molar is chosen as primary outcome.
Criteria will be the presence of a pocket distal to the mandibular second molar with a probing depth >7 mm and a probing clinical attachment level >6mm.
This study was designed as a single-blind research since subjects will be unaware of their treatment allocation. A software will be used to produce a random sequence of 18 integer numbers without duplicates generated from atmospheric noise and concealed in closed envelopes by one of the investigators. At the time of the patient's first surgery, the envelope will be opened and patient allocated either to group 1 (PRF on the right side, spontaneous healing on the left side), for allocation numbers 1-9, or group 2 (spontaneous healing on the right side, PRF on the left side), for allocation numbers 10-18.
One clinician, not involved in patient treatment and not aware of what therapeutic approach used for the different sites of treatment, will perform all clinical measurements (PD, CAL, gingival recession, plaque index and gingival bleeding index) before and after 12 and 18 weeks of surgery.
Clinical and radiographical measurements will be recorded at 12 and 18 weeks after the surgery. The Student t test will be used to compare the differences between the 2 groups.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Naples, Italien, 80131
- Gilberto Sammartino
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion criteria Patients of both genders and any race, between 18 and 35 year-old
- Periodontally health patients and treated periodontally compromised patients
- Enrollment on a regular supportive periodontal therapy (SPT) program.
- Full-mouth plaque score (FMPS)< 25% at baseline;
- Full-mouth bleeding score (FMBS)< 25% at baseline;
- Patients having bilateral mesioangular impacted mandibular third molars with the presence of a pocket distally to the mandibular second molar with a probing depth (PD) ≥7 mm
- Intact buccal and lingual cortical bone of the post-extraction site
Exclusion Criteria:
- General contra-indications for surgery (systemic disease, compromised immune system etc);
- Tobacco smoking
- Pregnancy and lactation
- Untreated periodontal conditions;
- Acute infection in the site of the extraction
- Patients taking any medications which might interfere with coagulation
- Platelet count < 150000/mm3
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: PRF (platelet-rich fibrin)
PRF will be used after the extraction of the third molar to prevent periodontal defects to second molar
|
After loco-regional anesthesia was administered, a full-thickness mucoperiosteal flap was raised.
The flap incision was extended from the vestibular side of the retromolar trigon to the second molar, corresponding to its distolingual cusp.
The incision continued intrasulcular at the second molar and proceeded with a release incision distally to the papilla between the first and second molars, on a 45° angle.
An osteotomy using a Lindemann burr under constant irrigation, followed by an odontotomy using a diamond burr was performed, if necessary
|
|
Aktiv komparator: spontaneous healing
after the extraction of the third molar the socket will be left to heal spontaneously
|
After loco-regional anesthesia was administered, a full-thickness mucoperiosteal flap was raised.
The flap incision was extended from the vestibular side of the retromolar trigon to the second molar, corresponding to its distolingual cusp.
The incision continued intrasulcular at the second molar and proceeded with a release incision distally to the papilla between the first and second molars, on a 45° angle.
An osteotomy using a Lindemann burr under constant irrigation, followed by an odontotomy using a diamond burr was performed, if necessary
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinical attachment level change
Tidsram: 12 and 18 weeks
|
the clinical attachment level is the distance between the gingival margin to the cemento-enamel junction. the measurement is made by using a Williams periodontal probe. Differences in changes are measured from baseline to 12 and 18 weeks. |
12 and 18 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
probing depth change
Tidsram: 12 and 18 weeks
|
The probing depth is the distance from the free end of the gingival margin to the bottom of the periodontal pocket.
The measurement is made by using a Williams periodontal probe.
Differences in changes are measured from baseline to 12 and 18 weeks.
|
12 and 18 weeks
|
|
gingival recession change
Tidsram: 12 and 18 weeks
|
The distance between the cemento-enamel junction and gingival margin gives the level of recession. The measurement is made by using a Williams periodontal probe. Differences in changes are measured from baseline to 12 and 18 weeks. |
12 and 18 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Gilberto Sammartino, Professor, Federico II University
Publikationer och användbara länkar
Allmänna publikationer
- Cabaro S, D'Esposito V, Gasparro R, Borriello F, Granata F, Mosca G, Passaretti F, Sammartino JC, Beguinot F, Sammartino G, Formisano P, Riccitiello F. White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds. Platelets. 2018 Jul;29(5):463-467. doi: 10.1080/09537104.2017.1319046. Epub 2017 Jun 21.
- Sammartino G, Dohan Ehrenfest DM, Carile F, Tia M, Bucci P. Prevention of hemorrhagic complications after dental extractions into open heart surgery patients under anticoagulant therapy: the use of leukocyte- and platelet-rich fibrin. J Oral Implantol. 2011 Dec;37(6):681-90. doi: 10.1563/AAID-JOI-D-11-00001. Epub 2011 Jun 30.
- Sammartino G, Tia M, Marenzi G, di Lauro AE, D'Agostino E, Claudio PP. Use of autologous platelet-rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars. J Oral Maxillofac Surg. 2005 Jun;63(6):766-70. doi: 10.1016/j.joms.2005.02.010.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 56/15
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Molar, tredje
-
Orlucent, IncAvslutadHudskada | Melanom (hud) | MolFörenta staterna
-
White Plains HospitalAktiv, inte rekryterandeBukspottskörtelcancer | Adenokarcinom i bukspottkörteln | Lynch syndrom | Bukspottkörtelcancer | HNPCC | Familjär bukspottkörtelcancer | Ärftlig pankreatit | BRCA 1/2 | FAMMM | Familjärt atypiskt multipelt mol melanom | Peutz Jeghers syndromFörenta staterna
-
H. Lee Moffitt Cancer Center and Research InstituteAktiv, inte rekryterandeLynch syndrom | Duktalt adenokarcinom i bukspottkörteln | Kronisk pankreatit | Bukspottkörtelcysta | Ataxi Telangiectasia | FAP | Peutz-Jeghers syndrom | PALB2 genmutation | BRCA-mutation | Fet bukspottkörtel | Genetisk bukspottkörtelcancer | Genetisk pankreatit | Familjärt atypiskt multipelt mol-melanomFörenta staterna
-
University of ArkansasIndragenPankreatiska neoplasmer | Kolorektala neoplasmer, ärftlig icke-polypos | BRCA1 genmutation | BRCA2 genmutation | Ärftlig pankreatit | Ataxi Telangiectasia | Peutz-Jeghers syndrom | Familjärt atypiskt mol-malignt melanomsyndromFörenta staterna